טוען...
Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Aspirin (Asp) is one of the most important and ancient member of nonsteroidal anti-inflammatory drugs (NSAID), commonly used in medication of fever, pain and inflammation. It can inhibit the synthesis of prostaglandin by blocking the cyclooxygenase (COX). Attempts have been taken to analyze aspirin...
שמור ב:
| הוצא לאור ב: | In Silico Pharmacol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7056757/ https://ncbi.nlm.nih.gov/pubmed/32181121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40203-020-0053-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|